Accounts Payable and Accrued Liabilities

6 Months Ended

Jun. 30, 2026

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities

8. Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consist of the following (in thousands):


			As of
			June 30, 2026						December 31, 2025
Accounts payable and other accrued operating expenses			$	74,555					$	79,907
Accrued clinical trial expenses			34,443						34,329
Accrued professional fees			25,014						23,658
Accrued technical operation expenses			21,730						22,533

Accrued compensation and employee related costs			61,579						111,514
Accrued royalty and milestones payable			37,774						17,101

Revenue Interest Payments payable			7,553						6,449
Accrued sales allowances and related costs			146,373						70,869
Accrued French rebate payable			9,062						6,960
Contingent consideration			—						57,799


Accrued milestone payment to AstraZeneca			—						15,000
Other accrued liabilities			10,846						9,941
			$	428,929					$	456,060